These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 6439141)

  • 1. Failure of chelation therapy in lead nephropathy.
    Germain MJ; Braden GL; Fitzgibbons JP
    Arch Intern Med; 1984 Dec; 144(12):2419-20. PubMed ID: 6439141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute renal failure in the course of occupational lead intoxication. Chelation therapy responsability (author's transl)].
    Yver L; Maréchaud R; Picaud D; Touchard G; d'Eyzac AT; Matuchansky C; Patte D
    Nouv Presse Med; 1978 May; 7(18):1541-3. PubMed ID: 97624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chelation therapy in lead nephropathy questioned.
    Sawyer HJ
    Arch Intern Med; 1985 Oct; 145(10):1927. PubMed ID: 3929710
    [No Abstract]   [Full Text] [Related]  

  • 4. ["Terzo fuoco", lead poisoning and chronic renal failure].
    Bonucchi D; Mondaini G; Ravera F; Minisci E; Albertazzi V; Arletti S; Mori G; Ballestri M; Piattoni J; Cappelli G
    G Ital Nefrol; 2007; 24 Suppl 38():76-9. PubMed ID: 17922453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and treatment of occupational lead nephropathy.
    Wedeen RP; Malik DK; Batuman V
    Arch Intern Med; 1979 Jan; 139(1):53-7. PubMed ID: 760684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removing lead from bone: clinical implications of bone lead stores.
    Wedeen RP
    Neurotoxicology; 1992; 13(4):843-52. PubMed ID: 1302310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental lead nephropathy: treatment with calcium disodium ethylenediaminetetraacetate.
    Sánchez-Fructuoso AI; Blanco J; Cano M; Ortega L; Arroyo M; Fernández C; Prats D; Barrientos A
    Am J Kidney Dis; 2002 Jul; 40(1):59-67. PubMed ID: 12087562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic chelation therapy in occupational lead poisoning: a review.
    Bridbord K; Blejer HP
    Am Ind Hyg Assoc J; 1977 Oct; 38(10):536-42. PubMed ID: 411363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-level environmental exposure to lead and progressive chronic kidney diseases.
    Lin JL; Lin-Tan DT; Li YJ; Chen KH; Huang YL
    Am J Med; 2006 Aug; 119(8):707.e1-9. PubMed ID: 16887418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychologic and postural sway improvement after Ca(++)-EDTA chelation for mild lead intoxication.
    Linz DH; Barrett ET; Pflaumer JE; Keith RE
    J Occup Med; 1992 Jun; 34(6):638-41. PubMed ID: 1619495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Case of lead nephropathy due to chronic occupational lead exposure].
    Ogata A; Sueta S; Tagawa M
    Nihon Jinzo Gakkai Shi; 2011; 53(2):207-11. PubMed ID: 21516708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of zinc supplementation during chelation therapy in plumbism: a case report.
    Finelli VN; Lerner S; Hong C; Lohiya G
    Med Lav; 1980; 71(2):149-56. PubMed ID: 6780775
    [No Abstract]   [Full Text] [Related]  

  • 13. Zinc supplementation of chelation therapy in saturnism. Preliminary study.
    Bădulici S; Chirilă M
    Rom J Intern Med; 1992; 30(3):211-5. PubMed ID: 1475600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased body lead burden--cause or consequence of chronic renal insufficiency?
    Marsden PA
    N Engl J Med; 2003 Jan; 348(4):345-7. PubMed ID: 12540649
    [No Abstract]   [Full Text] [Related]  

  • 15. Occult lead intoxication in patients with gout and kidney disease.
    Wright LF; Saylor RP; Cecere FA
    J Rheumatol; 1984 Aug; 11(4):517-20. PubMed ID: 6434739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases.
    Lin-Tan DT; Lin JL; Yen TH; Chen KH; Huang YL
    Nephrol Dial Transplant; 2007 Oct; 22(10):2924-31. PubMed ID: 17556414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lead and the kidney: nephropathy, hypertension, and gout.
    Perazella MA
    Conn Med; 1996 Sep; 60(9):521-6. PubMed ID: 8908777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lead, mercury and cadmium nephropathy.
    Wedeen RP
    Neurotoxicology; 1983; 4(3):134-46. PubMed ID: 6419181
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic lead poisoning: Lead gout with giant tophi on the skin, nephrophathy and porphyrinopathy].
    Orfanos CE; Künzig M
    Hautarzt; 1975 Nov; 26(11):581-4. PubMed ID: 812845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Does lead cause renal damage? Surprising results published in a respected journal].
    Elinder CG
    Lakartidningen; 2003 May; 100(19):1736. PubMed ID: 12800302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.